Home / BTBD2 Knockout Cell Lines

BTBD2 Knockout Cell Lines

Gene: BTBD2

Official Full Name: BTB domain containing 2provided by HGNC

Gene Summary: The C-terminus of the protein encoded by this gene binds topoisomerase I. The N-terminus contains a proline-rich region and a BTB/POZ domain (broad-complex, Tramtrack and bric a brac/Pox virus and Zinc finger), both of which are typically involved in protein-protein interactions. Subcellularly, the protein localizes to cytoplasmic bodies. [provided by RefSeq, Jul 2008]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO19361 BTBD2 Knockout cell line (HeLa) Human BTBD2 1:3~1:6 Negative Online Inquiry
KO19362 BTBD2 Knockout cell line (HCT 116) Human BTBD2 1:2~1:4 Negative Online Inquiry
KO19363 BTBD2 Knockout cell line (HEK293) Human BTBD2 1:3~1:6 Negative Online Inquiry
KO19364 BTBD2 Knockout cell line (A549) Human BTBD2 1:3~1:4 Negative Online Inquiry

Background

BTBD2 Gene Knockout Cell Lines are sophisticated biological tools specifically engineered to facilitate the study of the BTBD2 gene's role in various biological processes, including cell signaling, development, and disease pathways. These cell lines have been meticulously prepared using advanced CRISPR-Cas9 technology, resulting in complete and targeted disruption of the BTBD2 gene, enabling researchers to explore the functional consequences of its absence in a controlled environment.

The primary function of BTBD2 Gene Knockout Cell Lines is to serve as models for understanding genetic regulation and the implicated mechanisms of various diseases. By observing the cellular behavior, proliferation, and differentiation in the absence of BTBD2, researchers can elucidate the gene's role in processes such as protein homeostasis, inflammation, and tumorigenesis. These knockout models are instrumental in validating hypotheses in both fundamental research and in the development of targeted therapies.

Scientifically, BTBD2 Gene Knockout Cell Lines hold significant importance for both academic research and clinical applications. They can assist in identifying novel therapeutic targets for diseases linked to BTBD2 dysregulation, such as certain cancers and autoimmune disorders. Additionally, these cell lines pave the way for drug discovery by providing a platform to assess the efficacy of potential therapeutic agents in a genetically relevant context.

What sets our BTBD2 Gene Knockout Cell Lines apart from alternatives on the market is their high specificity and reliability of gene editing, coupled with the robust physiological relevance of the resulting cellular models. Unlike transient knockdown methods that may yield inconsistent results, our stable knockout lines guarantee reproducible outcomes essential for rigorous scientific inquiry.

For researchers and clinicians focusing on gene function and regulation, the BTBD2 Gene Knockout Cell Lines offer unparalleled value, facilitating a deeper understanding of complex biological pathways and enabling the identification of novel intervention strategies. Our commitment to excellence is backed by a team of experts dedicated to advancing genetic research through high-quality biological products.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.